Pivotal Therapeutics Inc. announced the appointment of Prakash Gowd as the company's Chief Financial Officer. Mr. Gowd succeeds Eugene Bortoluzzi, who will remain Pivotal's Chief Executive Officer. He joins Pivotal from Canadian investment bank, where he served as a Managing Director in the firm's healthcare investment banking unit.

Among his earlier achievements, Mr. Gowd was a equity research analyst at two national investment firms, managed the planning of new product and commercial development at a major pharmaceutical company and served as a Managing Director at a well-known strategic advisory firm working with major pharmaceutical companies. Mr. Gowd has been the Audit Chair and a director of a public drug developer and also as the CEO of a private drug discovery company.